Korean Journal of Clinical Neurophysiology  2016;18(1):14-17

doi:10.14253/kjcn.2016.18.1.14

Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome.

Jin Mo PARK 1 ; Nam Kyun KIM ; Jin Sung PARK

Affiliations

+expand

Keywords

Guillain-Barre syndrome; Intravenous immunoglobulin; Pulmonary thromboembolism

Country

Republic of Korea

Language

Korean

Abstract

Intravenous immunoglobulin (IVIG) is a safe treatment to treat various neurological disorders, but fatal thrombotic events as rare complications have been reported. A 54-year-old woman with Guillain-Barre syndrome complained of dyspnea during IVIG treatment. She was finally diagnosed with pulmonary thromboembolism. To the best of our knowledge, this is the first case of pulmonary thromboembolism associated with IVIG treatment in a Korean patient with Guillain-Barre syndrome.